Loading clinical trials...
Loading clinical trials...
Efficacy of Intra-Articular Bevacizumab in Preventing Recurrent Hemarthrosis in Hemophilia Patients With Chronic Synovitis: A Pre- and Post-Design Study
Conditions
Interventions
Intra-articular Bevacizumab
Locations
2
Pakistan
Hayatabad Medical Complex
Peshawar, KPK, Pakistan
Institute of Pathology and Diagnostic Medicine (IPDM)
Peshawar, KPK, Pakistan
Start Date
September 9, 2025
Primary Completion Date
March 28, 2026
Completion Date
April 15, 2026
Last Updated
September 23, 2025
NCT03961243
NCT06820515
NCT05500807
NCT07101926
NCT06379789
NCT07226206
Lead Sponsor
Khyber Medical University Peshawar
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions